4 weeks is nothing for a clinical trial. The efficacy of mc in epilepsy is already clearly established by lots of studies and trials done by companies which is why everybody is jumping on the bandwagon. It should be about demonstrating long term safety more then whether it works or not. Definitely not a game changer.
Before you try and accuse me of down ramping your up ramping i only have a biochemistry background and have no idea what i am talking about.
CR Clinical Study?, page-2
-
- There are more pages in this discussion • 10 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RGT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
30.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $14.00M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 3300 | 31.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 30.0¢ | 313 | 1 |
View Market Depth
| Last trade - 16.16pm 12/07/2024 (20 minute delay) ? |
| RGT (ASX) Chart |
Day chart unavailable